FDA sup­ports lim­it­ed dis­tri­b­u­tion of an­ti­smok­ing drug Chan­tix de­spite car­cino­gen risk

Ear­li­er this month, the FDA alert­ed the pub­lic that Pfiz­er had vol­un­tar­i­ly re­called its stop-smok­ing drug Chan­tix af­ter find­ing el­e­vat­ed lev­els of can­cer-caus­ing ni­trosamines. Now …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER